These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30958398)

  • 81. Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu.
    Takizawa I; Nishiyama T; Hara N; Isahaya E; Hoshii T; Takahashi K
    Prostate; 2010 Sep; 70(13):1395-401. PubMed ID: 20687212
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Editorial Commentary on "Racial Disparities in Diagnosis and Treatment of Depression Associated with Androgen Deprivation Therapy for Prostate Cancer".
    Khan HM
    Urology; 2024 Apr; 186():81. PubMed ID: 38395080
    [No Abstract]   [Full Text] [Related]  

  • 83. Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.
    Golla V; Kaplan AL
    Curr Urol Rep; 2017 Jul; 18(7):49. PubMed ID: 28589395
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
    Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
    Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Reply to Editorial Comment on "Racial Disparities in Diagnosis and Treatment of Depression Associated with Androgen Deprivation Therapy for Prostate Cancer".
    Shah MS; Lallas CD
    Urology; 2024 Apr; 186():82. PubMed ID: 38431158
    [No Abstract]   [Full Text] [Related]  

  • 86. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
    J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Androgen deprivation therapy for prostate cancer.
    Bahnson R
    J Urol; 2007 Oct; 178(4 Pt 1):1148. PubMed ID: 17698142
    [No Abstract]   [Full Text] [Related]  

  • 88. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.
    Yassin A; Salman M; Talib RA; Yassin DJ
    Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Variations in circulating sex steroid levels in metastatic prostate cancer patients with combined androgen blockade: observation and implication.
    Qin X; Zhang H; Ye D; Yao X; Zhang S; Dai B
    Andrology; 2013 May; 1(3):512-6. PubMed ID: 23536478
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
    Kaufman J
    Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Androgen deprivation and immunotherapy for the treatment of prostate cancer.
    Gamat M; McNeel DG
    Endocr Relat Cancer; 2017 Dec; 24(12):T297-T310. PubMed ID: 28814451
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Disseminated carcinoma of the prostate: monotherapy or complete androgenic blockade?].
    González Martín M; Gómez Veiga F; Alvarez Castelo L
    Arch Esp Urol; 1997 Dec; 50(10):1067-76. PubMed ID: 9494195
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer.
    Loughlin KR
    Urol Oncol; 2016 Nov; 34(11):482.e1-482.e4. PubMed ID: 27423822
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 96. What is the rationale for androgen therapy for women?
    Papalia MA; Davis SR
    Treat Endocrinol; 2003; 2(2):77-84. PubMed ID: 15871544
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Testosterone and depression in men.
    Amiaz R; Seidman SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):278-83. PubMed ID: 18438177
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of testosterone in managing advanced prostate cancer.
    Rove KO; Debruyne FM; Djavan B; Gomella LG; Koul HK; Lucia MS; Petrylak DP; Shore ND; Stone NN; Crawford ED
    Urology; 2012 Oct; 80(4):754-62. PubMed ID: 22795376
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.